TSX Venture Exchange (TSXV) · RP.V · ISIN CA76027P4006
RepliCel Life Sciences Inc.
No trading activity has been reported for this listing since February 28, 2025. It may be delisted, halted or inactive.
0.0150 CAD
February 28, 2025
RepliCel Life Sciences Inc. (RP.V) trades on the TSX Venture Exchange and operates in the Biotechnology industry. Its market capitalisation is approximately 1.1M CAD. Its ISIN is CA76027P4006. This page shows the latest available price, the day and 52-week ranges and an interactive chart. Quotes are delayed and are not intended for order execution.
Key facts
Exchange
TSX Venture Exchange (TSXV)
ISIN
CA76027P4006
Sector
Healthcare
Industry
Biotechnology
Country
CA
Market cap
1.1M CAD
Previous close
0.01 CAD
Day range
0.01 – 0.01
52-week range
0.01 – 0.07
Volume
269K
50-day average
0.01 CAD
200-day average
0.04 CAD
Asset type
Equity
About RepliCel Life Sciences Inc.
Headquartered in Vancouver, Canada, RepliCel Life Sciences Inc. is a regenerative medicine company dedicated to developing innovative autologous cell therapies. These treatments are designed to correct functional cellular deficiencies by harnessing a patient's own cells. The process involves isolating cells from harvested tissues, significantly expanding them in a controlled laboratory environment, and subsequently applying them therapeutically. The company's developmental portfolio includes several key product candidates: RCT-01 targets chronic tendinosis, RCS-01 addresses aging and sun-damaged skin, and RCH-01 is aimed at treating hair loss. Additionally, RepliCel is advancing RCI-02, a specialized dermal injection device. RepliCel has established significant strategic alliances. It holds a collaboration and technology transfer agreement with YOFOTO (China) Health Industry Co. Ltd. to establish a clinical research program and facilitate the commercialization of RCS-01 and RCT-01. A similar collaboration exists with Shiseido Company, Limited, focusing on the clinical research program for RCH-01. Furthermore, the company is engaged in a research project agreement with the University of British Columbia, contributing to the creation of a comprehensive hair follicle cell data map.
Company websiteFrequently asked
- What is the RP.V share price today?
- This page shows the latest available RepliCel Life Sciences Inc. (RP.V) price with its change against the prior close. Values are delayed or previous-close, not real-time.
- Where is RepliCel Life Sciences Inc. listed?
- RepliCel Life Sciences Inc. trades on the TSX Venture Exchange under the symbol RP.V, ISIN CA76027P4006.
- How large is RepliCel Life Sciences Inc.?
- Its market capitalisation is approximately 1.1M CAD, based on the latest available price and share count from our data provider.
+
+
+
All RepliCel Life Sciences Inc. data comes from exchange and provider feeds for the TSX Venture Exchange and is published for information, not as investment advice.
Real-time quotes are not licensed; prices are delayed or previous close, so they may lag the market by 15 minutes or a full session. Information only, not for trading. Where a figure is not covered by our licensed sources, the page says so rather than showing a substitute.